Zenas BioPharma, Inc. (ZBIO) Reports Q3 Loss of $5.02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: ZBIO) | Delayed: 28.83 +1.21 (4.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.62 | 52 Week High | $50.95 | |||
| Open | $27.85 | 52 Week Low | $18.06 | |||
| Day High | $29.05 | P/E | N/A | |||
| Day Low | $27.84 | EPS | $0.00 | |||
| Volume | 109,676 | |||||
